Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet with Low Dose Vitamin D for SHPT in Hemodialysis
NCT00803712Phase 4Completed
- Sponsor
- Amgen
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of cinacalcet in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Amgen. Primary endpoint: Achievement of a >= 30% Reduction in Mean PTH From Baseline at Month 6. Started Feb 2009; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00803712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803712.